indazoles has been researched along with arginyl-glycyl-aspartic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arap, W; Chanthery, YH; Kasman, IM; McDonald, DM; Ozawa, MG; Pasqualini, R; Varner, AS; Yao, VJ | 1 |
| Albert, DH; Fox, GB; Ji, S; Liu, S; Luo, Y; Mudd, SR; Shao, G; Voorbach, MJ; Zhang, Y; Zhou, Y | 1 |
2 other study(ies) available for indazoles and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels.
Topics: Adenoma, Islet Cell; Animals; Axitinib; Bacteriophage M13; Endothelial Cells; Female; Imidazoles; Indazoles; Integrin alpha5beta1; Integrin alphaVbeta3; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; Neovascularization, Pathologic; Oligopeptides; Pancreatic Neoplasms; Substrate Specificity | 2006 |
Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.
Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Dimerization; Female; Glioma; Humans; Indazoles; Integrin alphaVbeta3; Male; Mice; Mice, Nude; Multimodal Imaging; Oligopeptides; Organotechnetium Compounds; Peptides, Cyclic; Phenylurea Compounds; Positron-Emission Tomography; Prostatic Neoplasms; Protein-Tyrosine Kinases; Radiopharmaceuticals; Technetium; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2013 |